Cryofocus Medtech (Shanghai) Management
Management criteria checks 2/4
Cryofocus Medtech (Shanghai)'s CEO is Jun Zhu, appointed in Oct 2020, has a tenure of 4.08 years. total yearly compensation is CN¥12.19M, comprised of 20% salary and 80% bonuses, including company stock and options. directly owns 0.62% of the company’s shares, worth HK$10.29M. The average tenure of the management team and the board of directors is 4.1 years and 3.2 years respectively.
Key information
Jun Zhu
Chief executive officer
CN¥12.2m
Total compensation
| CEO salary percentage | 20.0% |
| CEO tenure | 4.1yrs |
| CEO ownership | 0.6% |
| Management average tenure | 4.1yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
Is Cryofocus Medtech (Shanghai) (HKG:6922) Using Too Much Debt?
Sep 02
We're Not Very Worried About Cryofocus Medtech (Shanghai)'s (HKG:6922) Cash Burn Rate
Jan 10Cryofocus Medtech (Shanghai) (HKG:6922) Is In A Good Position To Deliver On Growth Plans
Oct 03Companies Like Cryofocus Medtech (Shanghai) (HKG:6922) Are In A Position To Invest In Growth
May 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥106m |
| Mar 31 2024 | n/a | n/a | -CN¥102m |
| Dec 31 2023 | CN¥12m | CN¥2m | -CN¥97m |
| Sep 30 2023 | n/a | n/a | -CN¥105m |
| Jun 30 2023 | n/a | n/a | -CN¥113m |
| Mar 31 2023 | n/a | n/a | -CN¥113m |
| Dec 31 2022 | CN¥12m | CN¥2m | -CN¥112m |
| Dec 31 2021 | CN¥7m | CN¥2m | -CN¥102m |
| Dec 31 2020 | CN¥850k | CN¥836k | -CN¥137m |
Compensation vs Market: Jun's total compensation ($USD1.68M) is above average for companies of similar size in the Hong Kong market ($USD347.90K).
Compensation vs Earnings: Jun's compensation has increased whilst the company is unprofitable.
CEO
Jun Zhu (49 yo)
4.1yrs
Tenure
CN¥12,194,000
Compensation
Mr. Jun Zhu serves as Consultant at Proxima Ventures, where he was previously an External Consultant. Mr. Zhu serves as General Manager at Cryofocus Medtech (Shanghai) Co., Ltd. since October 2020 and ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 11.7yrs | no data | 0.036% HK$ 601.2k | |
| GM & Executive Director | 4.1yrs | CN¥12.19m | 0.62% HK$ 10.3m | |
| CFO, Joint Company Secretary & Executive Director | 4.1yrs | CN¥1.72m | no data | |
| Technical Director and R&D Manager | 5.7yrs | no data | no data | |
| Chief Medical Officer | 2.7yrs | no data | no data | |
| Executive Vice President of Ningbo SensCure | 7.8yrs | no data | no data | |
| Joint Company Secretay | 2.9yrs | no data | no data | |
| Deputy Vice President | 11.2yrs | no data | no data |
4.1yrs
Average Tenure
41yo
Average Age
Experienced Management: 6922's management team is considered experienced (4.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 11.7yrs | no data | 0.036% HK$ 601.2k | |
| GM & Executive Director | 3.8yrs | CN¥12.19m | 0.62% HK$ 10.3m | |
| CFO, Joint Company Secretary & Executive Director | 1.4yrs | CN¥1.72m | no data | |
| Independent Non-Executive Director | 2.9yrs | CN¥200.00k | no data | |
| Independent Non-Executive Director | 2.9yrs | CN¥280.00k | no data | |
| Non-Executive Director | 10.3yrs | no data | 9.15% HK$ 152.9m | |
| Supervisor | 4.4yrs | no data | no data | |
| Independent Non-Executive Director | 2.9yrs | CN¥200.00k | no data | |
| Non-Executive Director | 3.4yrs | no data | no data | |
| Independent Non-Executive Director | 2yrs | CN¥200.00k | no data | |
| Supervisor | 6yrs | no data | no data | |
| Chairperson of the Board of Supervisors | 1.5yrs | no data | no data |
3.2yrs
Average Tenure
50yo
Average Age
Experienced Board: 6922's board of directors are considered experienced (3.2 years average tenure).